Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Azacitidine (AZA) Treatment Prolongs Overall Survival (OS) in Higher-Risk MDS Patients Compared with Conventional Care Regimens (CCR): Results of the AZA-001 Phase III Study.

Pierre Fenaux, MD, G.J. Mufti, MD, V. Santini, MD, C. Finelli, MD, A. Giagounidis, MD, R. Schoch, MD, A.F. List, MD, S.D. Gore, MD, J.F. Seymour, MD, E. Hellstrom-Lindberg, MD, J.M. Bennett, MD, J.C. Byrd, MD, J.T. Backstrom, MD, L.S. Zimmerman, BSN, D.R. McKenzie, MS, C.L. Beach, PharmD, L.R. Silverman, MD

Blood (2007) 110 (11): 817.

https://doi.org/10.1182/blood.V110.11.817.817

Published: 2007

Journal Articles

Combination Chemotherapy with CHOP-Daclizumab in HTLV-I Associated Adult T-Cell Leukaemia/Lymphoma.

S. Simpson, M. Thanigaikumar, G. Taylor, E. Matutes, P. Fields, S. Devereux, A. Ho, G.J. Mufti, A. Pagliuca

Blood (2006) 108 (11): 2750.

https://doi.org/10.1182/blood.V108.11.2750.2750

Published: 2006

Journal Articles

Outcome of Second Allogeneic Transplants Using Reduced Intensity Conditioning Following Relapse after an Initial Allogeneic Transplant.

B.E. Shaw, G.J. Mufti, S. Mackinnon, J. Cavenagh, K. Towlson, R. Pearce, A. Pagliuca, J. Apperley, C. Craddock, M. Kazmi, T. Littlewood, D. Milligan, D. Marks, Nigel H. Russell

Blood (2006) 108 (11): 3660.

https://doi.org/10.1182/blood.V108.11.3660.3660

Published: 2006

Journal Articles

Real-Time Detection of PML-RARA and RARA-PML Fusion Transcripts in High Risk Acute Promyelocytic Leukemia (APL) Treated with Arsenic Trioxide (ATO): Implications for Realization of Pre-Emptive Therapy for Molecular Relapse.

David Grimwade, J.V. Jovanovic, D. Diverio, E. Nugent, A.Y. Ho, G.J. Mufti, R.K. Hills, E. Solomon, R.E. Clark, F. Lo Coco, A.K. Burnett

Blood (2006) 108 (11): 493.

https://doi.org/10.1182/blood.V108.11.493.493

Published: 2006

Journal Articles

Single Centre Experience of Patients with Haematological Malignancies Admitted to Intensive Care Unit: A Comparative Review of Allogenic Bone Marrow Transplant Data.

Zi Yi Lim, Jane Graham, Sylvia Simpson, Stephen Devereux, Antonio Pagliuca, Aloysius Ho, G.J. Mufti

Blood (2004) 104 (11): 1830.

https://doi.org/10.1182/blood.V104.11.1830.1830

Published: 2004

Journal Articles

Effect of Costimulation and the Microenvironment on Antigen Presentation by Leukemic Cells

A.G.S. Buggins, N. Lea, J. Gäken, D. Darling, F. Farzaneh, G.J. Mufti, W.J.R. Hirst

Blood (1999) 94 (10): 3479–3490.

https://doi.org/10.1182/blood.V94.10.3479.422k29_3479_3490

Published: 1999

NARROW

Azacitidine (AZA) Treatment Prolongs Overall Survival (OS) in Higher-Risk MDS Patients Compared with Conventional Care Regimens (CCR): Results of the AZA-001 Phase III Study.

Combination Chemotherapy with CHOP-Daclizumab in HTLV-I Associated Adult T-Cell Leukaemia/Lymphoma.

Outcome of Second Allogeneic Transplants Using Reduced Intensity Conditioning Following Relapse after an Initial Allogeneic Transplant.

Real-Time Detection of PML-RARA and RARA-PML Fusion Transcripts in High Risk Acute Promyelocytic Leukemia (APL) Treated with Arsenic Trioxide (ATO): Implications for Realization of Pre-Emptive Therapy for Molecular Relapse.

Single Centre Experience of Patients with Haematological Malignancies Admitted to Intensive Care Unit: A Comparative Review of Allogenic Bone Marrow Transplant Data.

Effect of Costimulation and the Microenvironment on Antigen Presentation by Leukemic Cells

Email alerts

ASH Publications

American Society of Hematology

Azacitidine (AZA) Treatment Prolongs Overall Survival (OS) in Higher-Risk MDS Patients Compared with Conventional Care Regimens (CCR): Results of the AZA-001 Phase III Study.

Combination Chemotherapy with CHOP-Daclizumab in HTLV-I Associated Adult T-Cell Leukaemia/Lymphoma.

Outcome of Second Allogeneic Transplants Using Reduced Intensity Conditioning Following Relapse after an Initial Allogeneic Transplant.

Real-Time Detection of PML-RARA and RARA-PML Fusion Transcripts in High Risk Acute Promyelocytic Leukemia (APL) Treated with Arsenic Trioxide (ATO): Implications for Realization of Pre-Emptive Therapy for Molecular Relapse.

Single Centre Experience of Patients with Haematological Malignancies Admitted to Intensive Care Unit: A Comparative Review of Allogenic Bone Marrow Transplant Data.

Effect of Costimulation and the Microenvironment on Antigen Presentation by Leukemic Cells

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only